Prof @Rayazamalik team @OfficialUoM๐ฌ๐ง @WCMQatar๐ถ๐ฆ tweets about research on corneal confocal microscopy #CCM๐๏ธ a #biomarker for #neurodegenerative diseases
Joined August 2014
- Tweets 399
- Following 1,836
- Followers 2,127
- Likes 453
123 Photos and videos
ENA Group ๐๏ธ retweeted
15 Jul 2025
WCM-Q clinician scientist @Rayazamalik ranked number one medical researcher in #Qatar for third year running. Congratulations ๐ฅ
@TheLancet @QF @Cornell @WeillCornell @WCMQresearch @CornellRsrch
qatar-weill.cornell.edu/mediโฆ
3
9
430
ENA Group ๐๏ธ retweeted
15 May 2025
Read the full study here: onlinelibrary.wiley.com/doi/โฆ
1
1
172
ENA Group ๐๏ธ retweeted
15 May 2025
Our intuition often misleads us into thinking that general obesity carries the same risk as central obesity. Our study shows that visceral, not subcutaneous, fat drives peripheral #neuropathy through diabetes, hypertension, inflammation, and vascular disease.
2
1
1
319
8 Feb 2025
X was once a valuable platform for exchanging ideas. However, with the amplification of misinformation, messages getting buried, and the ownerโs retweeting of false content, it is no longer a platform for meaningful conversations.
229
ENA Group ๐๏ธ retweeted
12 Jan 2025
Our latest research on CCM shows that corneal endothelial cell density is significantly reduced in dementia and is associated with cortical gray matter atrophy, while corneal nerve fiber loss is evident in both mild cognitive impairment and dementia. alz-journals.onlinelibrary.wโฆ
2
9
527
4 Jan 2025
As AI advances in the analysis of corneal nerve morphology, @Yiannaras et al., from Prof. @Rayazamalik's lab, showed that corneal confocal microscopy (CCM) can distinguish patterns of neurodegeneration in multiple sclerosis and epilepsy. Read more: pubmed.ncbi.nlm.nih.gov/3967โฆ
1
1
4
399
ENA Group ๐๏ธ retweeted
13 Dec 2024
Ioannis N. Petropoulos et al. @Yiannaras @GroupENA @WCMQresearch report that Corneal Confocal Microscopy Identifies and Differentiates Patients With Multiple Sclerosis and Epilepsy, tvst.arvojournals.org/articlโฆ.
1
1
240
ENA Group ๐๏ธ retweeted
22 Nov 2024
Pleasure to present on neuropathy in prediabetes & diabetes at the 29th TMIMS international symposium: a new era for diagnosis and treatment of #diabetic_neuropathy at the Tokyo Metropolitan Institute of Medical Science. Thank you Dr Odriozola & Dr Sango for the kind invitation!
1
11
647
ENA Group ๐๏ธ retweeted
18 Nov 2024
Weight management in diabetes: study highlights neuroprotective role of weight loss medications
On Neurodiab website a signaling of articles on #diabeticneuropathy
The 149th NEUROdiab Publication News is by Mette Krabsmark Borbjerg (neurodiab.eu/publication-newโฆโฆ)
6
8
584
ENA Group ๐๏ธ retweeted
14 Nov 2024
Did you know diabetic neuropathy affects millions of people, leading to distressing complications which affect well-being? This @WorldDiabetesDay, @NEUROdiab_eu Youth Committee is working to improve well-being & reduce the impact of #neuropathy. Together, we can make a difference
10
13
1,508
ENA Group ๐๏ธ retweeted
19 Nov 2024
Honored to celebrate 10 years at Weill Cornell Medicine-Qatar! Proud to contribute to CCM research on neurological disorders with Prof. Malik's team and mentor medical students through the AOC program. Grateful for the journey and the impact we've made together!
2
11
815
ENA Group ๐๏ธ retweeted
11 Nov 2024
Choosing diabetes medications that promote weight loss may help reduce nerve damage, improve long-term outcomes for patients. Weight management is crucial in diabetes care.
2
2
309
ENA Group ๐๏ธ retweeted
11 Nov 2024
Their study found that people with type 2 diabetes on medications that cause weight gain had worse nerve damage and a greater loss of corneal nerves over time compared to those on weight loss medications.
1
2
2
310
ENA Group ๐๏ธ retweeted
11 Nov 2024
Obesity is a major risk factor for diabetic peripheral neuropathy (DPN) in type 2 diabetes. This study investigated the effect of glucose lowering medication associated with weight change on DPN.
1
2
2
255
ENA Group ๐๏ธ retweeted
11 Nov 2024
Check out the new work from @GPonirakis and colleagues:
Glucose lowering medication associated with weight loss may limit the progression of diabetic neuropathy in type 2 diabetes
onlinelibrary.wiley.com/doi/โฆ
#JPNSXHighlights
1
2
3
323
ENA Group ๐๏ธ retweeted
9 Sep 2024
Thank you, all, for a truly great #NeuroDiab2024
๐ฉ๐ฐ๐ฎ๐น
@GPonirakis @Yiannaras @Rayazamalik @johanroeikjer @KenderZoltan @VinniRasmussen @MSjoegaard @MetteBorbjerg
1
4
8
483
ENA Group ๐๏ธ retweeted
5 Sep 2024
FCS leads to small fibre nerve damage, clinical neuropathy & early CAN
@Neurodiab_eu
@heartukcharity
@CVD_MFT
@RareDiseases
@CheckOrphan
5
14
813
ENA Group ๐๏ธ retweeted
6 Sep 2024
Great work by @GPonirakis from Rayaz Malik group showing the variables associated with large and small fibre #neuropathy in people with and without T2 #diabetes . It highlights the links between visceral #obesity and health beyond BMI @Neurodiab_eu #neurodiab2024
1
6
14
773
ENA Group ๐๏ธ retweeted
28 Aug 2024
Professor @Rayazamalik and Dr @Yiannaras, @GroupENA, discuss their work on a new, non-invasive, inexpensive way of detecting early stages of #neurodegeneration that could be as easy as an #opticians appointment.
DOI: bit.ly/3MJ4rgF
Listen: buzzsprout.com/582022/156555โฆ
1
5
10
44,032
ENA Group ๐๏ธ retweeted
28 Aug 2024
Could an eye camera be a game-changer in the diagnosis of neurodegenerative diseases? ๐ง ๐ฌ
We think yes!
In this podcast, we argue that corneal confocal microscopy makes sense as a biomarker and look into the future.
Shout out to the team @ResearchpodHQ for hosting us ๐๐ซก
28 Aug 2024
Explore more from the researchers' institution: @WCMQatar, @WCMQresearch
1
4
341